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Abstract: In the traditional fermentative model yeast Saccharomyces cerevisiae, ScIxr1 is an HMGB
(High Mobility Group box B) protein that has been considered as an important regulator of gene
transcription in response to external changes like oxygen, carbon source, or nutrient availability.
Kluyveromyces lactis is also a useful eukaryotic model, more similar to many human cells due to its
respiratory metabolism. We cloned and functionally characterized by different methodologies KlIXR1,
which encodes a protein with only 34.4% amino acid sequence similarity to ScIxr1. Our data indicate
that both proteins share common functions, including their involvement in the response to hypoxia
or oxidative stress induced by hydrogen peroxide or metal treatments, as well as in the control of
key regulators for maintenance of the dNTP (deoxyribonucleotide triphosphate) pool and ribosome
synthesis. KlIxr1 is able to bind specific regulatory DNA sequences in the promoter of its target
genes, which are well conserved between S. cerevisiae and K. lactis. Oppositely, we found important
differences between ScIrx1 and KlIxr1 affecting cellular responses to cisplatin or cycloheximide in
these yeasts, which could be dependent on specific and non-conserved domains present in these
two proteins.
Keywords: Kluyveromyces lactis; IXR1; cisplatin sensitivity; hypoxia; dNTP pool
1. Introduction
Easy manipulation and availability of high throughput platforms to evaluate the
response of yeast cells to directed mutations and drugs strengthen the rationale of using
these organisms as disease models, or for testing chemical libraries to find new therapeutic
treatments [1–3]. Saccharomyces cerevisiae, Candida albicans, or Schizosaccharomyces pombe [4]
have been traditionally used with this purpose or as cell factories, but there are many other
yeasts that could be also included as far as the knowledge of their biology and regulatory
molecular mechanisms controlling principal functions would increase. Kluyveromyces
lactis is a good candidate that has been extensively studied in the last twenty years as a
non-conventional yeast [5].
The HMGB protein family is characterized for presenting one or more HMG-box
domains with DNA/RNA binding abilities. In multicellular eukaryotes, these proteins are
implicated not only in many DNA-dependent nuclear processes at the chromatin level [6]
(sequence and non-sequence specific), but also in the cytoplasm [7], or extracellularly
acting in cell signaling and inflammation [8]. In the nucleus HMGB proteins from yeast
and other higher eukaryotes are functionally involved in chromatin interactions, DNA
repair, transcriptional regulation, and epigenetic control of gene expression. Cytoplasmic
functions of HMGB proteins, like human HMGB1, are related to the balance between
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apoptosis and autophagy [9]. The binding of HMGB1 to beclin1 promotes autophagy and
simultaneously inhibits apoptosis [10], meanwhile the interaction of HMGB1 with p53
diminishes HMGB1-beclin1 interactions in the cytoplasm and promotes apoptosis [11].
Besides, HMGB proteins may function as alarmins and coordinate multicellular responses
during immune response and inflammation [12]. Interestingly, HMGB proteins are also
associated with diverse diseases like cancer [13], kidney disease [14], rheumatoid arthri-
tis [15], Alzheimer’s disease [16], among many others [17]. HMGB proteins are well
characterized in S. cerevisiae, a yeast with a predominant fermentative metabolism [18],
but not in other yeasts, like K. lactis, envisaged as an advantageous eukaryote model with
respiratory metabolism [19,20]. It has been proposed that during aerobic growth, the high
oxidative metabolism observed in K. lactis depends on the pentose phosphate pathway
(PPP) and on a very active mitochondrial respiration [20].
In S. cerevisiae, seven HMGB proteins have been characterized, ScAbf2, ScHmo1,
ScIxr1, ScNhp6A, ScNhp6B, ScNhp10, and ScRox1, but their homologs in other yeast
are less known. ScRox1 (regulation by oxygen 1) and ScIxr1 (intrastrand cross (X)-link
recognition 1) proteins take part in the regulation of ScHEM13 (HEMe biosynthesis 13) and
other hypoxic genes [21–26]. In aerobiosis, ScRox1, in cooperation with ScMot3 (modifier
of transcription 3), represses the expression of ScHEM13 [14,27] and also represses ScIXR1
expression [23]. During hypoxia, ScROX1 is downregulated, ScIXR1 expression rises,
and ScIxr1 activates ScHEM13 transcription [23]. ScIxr1 also participates in the oxidative
response caused by hydrogen peroxide in S. cerevisiae [23]. Besides, the protein binds
to the adducts that cisplatin forms with DNA [27] and its depletion causes increased
resistance to cisplatin [28]. The transcriptional regulation on ribosomal RNAs and genes
encoding ribosomal proteins or involved in ribosome assembly exerted by ScIxr1 is directly
related to S. cerevisiae response to cisplatin treatment [29,30]. ScIxr1 is also required for the
maintenance of an adequate supply and balance of dNTPs for DNA synthesis [31,32] and
repair [33], exerting a regulatory control of ScRNR1 (ribonucleotide reductase 1) expression
and participating in the genome integrity checkpoint signaling pathway leaded by the
kinases ScMec1 (mitosis entry checkpoint 1) and ScRad53 (radiation sensitive 53).
Considering K. lactis as an alternative model to S. cerevisiae, showing a predominant
respiratory metabolism, functional characterization of HMGB proteins in this yeast and
comparative analyses in reference to those of S. cerevisiae is a pending task that may report
important insights about their role as master regulators in response to changes in environ-
mental conditions, which have huge regulatory influences in unicellular eukaryotes [20,34].
In K. lactis, transcriptional factors are among those proteins showing the lowest similitude
to their S. cerevisiae counterparts, and besides, functional homology is also limited [19–21].
This rule is applicable to HMGB proteins. KlRox1, the only HMGB protein studied in
K. lactis so far [35], does not regulate the hypoxic response [36,37], but participates in
the response to cadmium and arsenate by regulating the KlYCF1 promoter [35]. In this
work, we cloned and functionally characterized KlIXR1, which encodes a protein with only
34.4% sequence similarity to ScIxr1. Our data indicate that both proteins share common
functions, including their involvement in the response to hypoxia or induced oxidative
stress, as well as in the control of key regulators for maintenance of the dNTP pool and
ribosome synthesis. Nevertheless, we found differences between ScIxr1 and KlIxr1 affecting
cellular responses to cisplatin or cycloheximide. These characteristics might be considered
when using K. lactis as a eukaryote model for high throughput screenings.
2. Materials and Methods
2.1. Yeast Strains, Media, and Growth Condition
The S. cerevisiae strain W303 and its isogenic derivative W303-ixr1∆ have been previ-
ously described [37]. The K. lactis strain MW190-9B (MATa, lac4-8, uraA, Rag+) was kindly
provided by M. Wesolowski-Louvel (Université Claude Bernard, France).
Cells were grown at 30 ◦C in YPD (2% glucose (w/v), 2% bacto-peptone (w/v), 1% yeast
extract (w/v)), or complete media, CM, prepared as reported [38] with different carbon
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sources or specific nutrient omissions as specified. Media for hypoxic growth were sup-
plemented with 0.002% ergosterol in ethanol (w/v) and 0.5% Tween 80 (v/v). Ergosterol
biosynthesis in yeast is limited in hypoxic conditions by defects in specific enzymes that
depend on oxygen and heme as an essential substrate or cofactor, meanwhile surfactant
Tween 80 maintains ergosterol soluble in polar solvent and is available to be taken up
by the cell. The AnaeroGen system (Oxoid Ltd., Dublin, Ireland) was used for hypoxic
growth, and oxygen levels were monitored by the BR55 indicator strip (Oxoid Ltd., Dublin,
Ireland). For analysis of resistance to metals, cisplatin was added to the media in the form
of cis-dichlorodiammineplatinum (II) (Sigma Aldrich Chemicals Co., St. Louis, MO, USA),
and Cd (II) was added to the media in the form of cadmium sulphate 8/3-hydrate (Sigma
Aldrich Chemicals Co., St. Louis, MO, USA). All concentrations are specified in the text
and figures. For analysis of the petite phenotype, hemin (Sigma Aldrich Chemicals Co.,
St. Louis, MO, USA) was added at a final concentration of 50 µg/mL and S-adenosyl
homocysteine (Sigma Aldrich Chemicals Co., St. Louis, MO, USA) at a final concentration
of 1 mM.
2.2. General Techniques
DNA isolation, propagation, and modification were carried out using standard
techniques as previously described [39]. Yeast genomic sequences were obtained from
the Saccharomyces Genome Database (SGD) maintained at Stanford University (http://
www.yeastgenome.org; last accessed date: 1 April 2021) or from Ensembl (https://fungi.
ensembl.org/index.html; last accessed date: 1 April 2021) databases. In silico analyses
of promoters were done with RSA (Regulatory Sequence Analysis) tools (http://rsat.sb-
roscoff.fr; last accessed date: 11 April 2021) and YEASTRACT (Yeast Search for Tran-
scriptional Regulators and Consensus Tracking) repository (http://www.yeastract.com;
last accessed date: 11 April 2021), using the consensus sequences YYYATTGTTCTC and
KTTSAAYKGTTYASA, previously described for ScIxr1 binding in S. cerevisiae [23,24]. The
primers used in this work are described in Supplementary Table S1.
The clone of KlIXR1 in the shuttle vector YEplac195 [40] was obtained by PCR amplifi-
cation of genomic DNA from the K. lactis strain YRRL-Y1140 with the primers ECV719 and
ECV720 (Table S1). The PCR product, containing the KlIXR1 ORF (Open Reading Frame), a
698 bp upstream region, and a 643 bp downstream region, was digested with the enzymes
SphI and SalI (included in the PCR primers) and introduced in the same sites of the MCS
(Multi Cloning Site) of the plasmid.
The clone of KlIXR1 ORF in the vector pAG426GAL-ccdB-EGFP (Addgene plasmid
#14203) was obtained by PCR amplification of genomic DNA from the K. lactis strain
YRRL-Y1140 with the primers AJVV024f and AJVV025r (described in Table S1). A 6xHis
sequence was included in AJVV024f primer for N-terminus tagging of protein product.
Both clones, YEplac195-KlIXR1 and pAG426GAL-KlIXR1, were verified by restriction
analysis and sequenced.
2.3. Construction and Verification of the KlIXR1 Null Strain
The construction YEplac195-KlIXR1 was used as template for inverse PCR with di-
vergent primers, ECV763 and ECV764, carrying NotI restriction sites at the 5’ ends, and
producing an internal deletion between positions +118 and +1075 of the KlIXR1 cod-
ing sequence. The kanMX4 cassette obtained from the pFA6-kanMX4 plasmid [41] was
then introduced between NotI sites by T4 ligation. This new construction, YEplac195-
KlIXR1::kanMX4, was used as template to amplify by PCR using the ECV765 and ECV766
primers. The resulted linear fragment contained the marker for geneticin (G418) selection
and two flanking regions of homology to the K. lactis genome, extended to 730 bp in the
5′ region up the KlIxr1 deletion and to 664 bp in the 3′ region. Cells of the K. lactis strain
MW190-9B transformed with this fragment were selected in CM plates supplemented with
200 µg/mL geneticin. To verify, the correct replacement in the K. lactis genome was verified
by PCR as previously described [42]. Genomic DNAs isolated from the MW190-9B strain
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(wild type) and the null candidates were amplified by PCR combining one internal primer
designed for annealing inside kanMX4 (ECV315K2 and ECV314K3) with one external
primer designed for annealing in the genome flanking to KlIXR1 gene, but external to
the regions of homology used for the recombination event (ECV808AR and ECV809AR,
respectively). The correct size of the expected amplicons was verified (Supplementary
Figure S1).
2.4. Northern Blotting
RNA was isolated from S. cerevisiae or K. lactis yeast cells grown in different media
to A600 = 0.8, and analyzed as described previously [39] with minor modifications. PCR
amplification with specific primers were used to obtain DNA probes for each gene (Table
S1). For each condition, three independent Northern blot experiments were performed
to ensure reliable results. Data from all the analysis were included in the quantification,
but figures only show one representative experiment. Results were normalized for RNA
loading against the signal obtained from the control probe, KlSNR17A. The value 1 in
arbitrary units (A.U.) was designed to control experiment and used as the reference for
re-scaling the other signals.
2.5. Analysis of Expression by RT-qPCR
Total RNA isolated as previously described was converted into cDNA and labeled
with the One-step NZYSpeedy RT-qPCR Green kit (NZYTech, Lisboa, Portugal). PCR
primers were designed following procedures previously described [43]. The sequence
of primers is available in Supplementary Material online resources accompanying this
paper (Supplementary Table S1). The StepOnePlus Real-Time PCR System was used for
the experiments (Applied Biosystems, Austin, TX, USA) and calculations were made by
the 2−∆∆Ct method [44]. Three independent RNA extractions and two technical replicates
were assayed for each strain or condition. The mRNA levels of the selected genes were
corrected by the geometric mean of the mRNA levels of KlTAF10, previously verified to be
constitutive in the assayed conditions and not affected by the deletion. A paired Student’s
t-test with two-tails was applied to evaluate the differences between ∆Ct values (Ct values
normalized with reference gene) of control and treated samples. A p-value lower than
0.05 was considered significant, although results with a significance lower of 0.01 were
also indicated.
2.6. Isolation of KlIxr1 Protein
Protein samples used in the EMSA assays were obtained by expressing full-length
KlIxr1, fused at its N-terminus to a 6xHis tag, in E. coli BL21-DE3 cells (Sigma Aldrich
Chemicals Co., St. Louis, MO, USA). The ORF was amplified from the YEplac195-KlIXR1
construction by PCR, using the primers AVV021 and AVV022 (Table S1). The DNA insert,
previously digested with the enzymes VspI and HindIII, was ligated into the expression
vector pOPTH ([ampr ori 2µm His6]) digested with the enzymes NdeI and HindIII. The
new construction, pOPTH-KlIXR1, was verified by restriction analysis and sequencing.
Competent E. coli BL21-DE3 cells were transformed with pOPTH-KlIXR1 and grown in
LBA at 37 ◦C to reach OD600 = 1.0. Then, expression was induced with 0.1 mM IPTG
(isopropyl-alfa-D-thiogalactopyranoside, Sigma Aldrich Chemicals Co., St. Louis, MO,
USA), and growth was continued during 3 h at 37 ◦C. After expression, cell pellets were
collected and lysed by sonication in high salt lysis buffer (50 mM Tris-HCl buffer pH
8.0, 1 M NaCl, 2 mM dithiothreitol and 2× Complete Mini EDTA-free protease inhibitor
cocktail from Roche, Switzerland). After clarification by centrifugation 30 min at 23,000× g,
lysates were passed through HisTrap HP Column, 5 mL (GE Healthcare, Chicago, IL,
EEUU) equilibrated in wash buffer A (50 mM Tris-HCl buffer pH 8.0, 100 mM NaCl,
2 mM dithiothreitol). Proteins were eluted in an AKTA prime plus (GE Healthcare, EEUU)
by linear gradient from 0 to 100% of buffer elution B (50 mM Tris-HCl buffer pH 8.0,
100 mM NaCl, 2 mM dithiothreitol, 300 mM imidazole). After elution, protein was further
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purified by gel filtration chromatography using a HiLoad™ 16/600 Superdex™ 200 pg
column (GE Healthcare, Chicago, IL, EEUU) pre-equilibrated with SEC buffer (20 mM
Tris-HCl buffer pH 8.0, 100 mM NaCl, 1 mM dithiothreitol, 1 mM EDTA). The protein was
concentrated by ultrafiltration using Amicon Ultra 15 mL Centrifugal Filters, 10 kDa (Merck,
Darmstadt, Germany). Final homogeneity of KlIxr1 protein was verified by SDS-PAGE
(Supplementary Figure S2), observing a protein with the expected size (51.3 kDa).
2.7. Electrophoretic Mobility Shift Assay
EMSA (Electrophoretic Mobility Shift Assay) assays were carried out to test KlIxr1
binding to the KlHEM13 and KlYCF1 promoters. The desired promoter target was obtained
after annealing complementary primers described in Supplementary Table S1, by mixing
the complementary oligonucleotides in equimolar amounts, heating to 95 ◦C for 5 min,
and cooling slowly to room temperature in darkness. The 5′-ends of forward primers were
fluorescein-labeled (FAM) for fluorescence detection. The binding reactions (20 µL) were
performed at 4 ◦C for 30 min in the buffer previously described [21] with 500 nM DNA 5′
labeled, 1 µg of the assayed protein, and 1 µg of calf thymus DNA (Sigma-Aldrich, USA)
as carrier. In competition experiments, an excess (1-, 2-, 5- or 100-fold molar) of the same
or mutated versions of unlabeled promoter fragment were used as a specific competitor.
A 100-fold molar excess of non-labeled fragmented salmon sperm DNA (Sigma Aldrich
Chemicals Co., St. Louis, MO, USA) was used as the nonspecific competitor (data not
shown). Samples were electrophoresed as previously described [29] and the gels scanned
for fluorescence in a Typhoon FLA 7000 Biomolecular Imager v.1.2 (GE Healthcare, Chicago,
IL, USA) to detect the FAM fluorophore, using 473 nm laser excitation and an Y520 filter.
2.8. Fluorescence Anisotropy Experiments
FAM-labeled dsDNA oligonucleotides (see Supplementary Table S1) were extensively
dialyzed against the buffer (10 mM Tris-HCl pH 8.0, 100 mM KCl, 2 mM DTT, 1 mM
EDTA, 500 µg/mL bovine serum albumin). Fluorescence anisotropy (FA) titrations were
performed at 25 ◦C on a Multi-modal Synergy H1 plate reader (Biotek, Winooski, VT,
USA) using 384 Low Volume Black Round Bottom Polystyrene NBS Microplate (Corning,
New York, NY, USA) with 15 µL per well. The excitation and detection wavelengths were
485 and 528 nm, respectively, with dichroic mirror (510 nm) and polarizer filter assembled.
Tumbling rates or changes in the rotational times of the small labelled-DNAs, when tightly
bound to large proteins, were used to calculate fluorescence anisotropy values. In each
titration, the fluorescence anisotropy of a solution of 100 nM FAM-tagged duplex DNA was
measured, normalized, and represented in a percentage of ligand bound as a function of the
added protein concentration. For each competition experiment, the polarization signal was
followed over time. As a result, a 30 min incubation period was selected as an adequate
time to reach equilibrium (data not shown). Binding data were fitted to a simple one site
saturation-binding model by nonlinear least squares regression using GraphPad Prism
6.0 (GraphPad Software Inc., San Diego, CA, USA). Each titration was performed three
times, and the final affinity was taken as the mean of these measurements. In competition
experiments, IC50 values were determined using GraphPad Prism 6.0.
2.9. Bioinformatics Analysis and 3-D Modelling
Alignment was done by the local alignment tool LALIGN (https://www.ebi.ac.uk/
Tools/psa/lalign/; last accessed date: 5 February 2021) using the BLOSUM50 matrix
and edited by ESPript 3 (http://espript.ibcp.fr/ESPript/ESPript/index.php; last accessed
date: 5 February 2021). 3-D Homology modelling of KlIxr1 and ScIxr1 HMG-box domains
was done by Phyre2 server [45] (http://www.sbg.bio.ic.ac.uk/phyre2/html/page.cgi?
id=index; last accessed date: 6 May 2021), based on protein templates human HMGB1
(PDB 2E6O), human SOX9 (PDB 4EUW), human SOX17 (PDB 2YUL), and Tox2 protein
from Mus musculus (PDB 2CO9) in the Protein Data Bank (http://www.rcsb.org; last
accessed date: 6 May 2021). Protein model pictures were made with the PyMol package
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v1.7 (www.pymol.org, 1st February 2014) and structure similarities were analyzed with the
TM-align tool [46] (https://zhanggroup.org/TM-align/; last accessed date: 15 May 2021).
3. Results
3.1. Heterologous Expression of KLLA0E18481g (KlIXR1) in Saccharomyces Cerevisiae Does Not
Complement the Increased Resistance to Cisplatin Observed in the S. cerevisiae ixr1∆ Mutant
A pairwise local alignment of the amino acid sequences of the ORFs YKL032c, the
ScIxr1 protein of S. cerevisiae, and KLLA0E18481g (KlIxr1) from K. lactis reveals only
34.4% amino acid sequence similarity (considered as substitutions for amino acids of
the same chemical group) and 26.7% identity between these two proteins.
In fact, the region actually conserved extends only to the sequence that includes the
two HMG-box domains present in both proteins. The long traits of poly-glutamines and
asparagines found in ScIxr1 do not exist in KlIxr1 and a region with repeated glutamines
and alanines present in KlIxr1 is absent in ScIxr1 (Figure 1a). The conserved amino acid
sequences in the HMG domains have been aligned with the program LALIGN showing a
91.3% similarity and 70.3% identity between both HMG-box tandem regions (Figure 1a).
Additionally, their structures were modeled and superposed to show that these domains
fold apparently in a similar way in the two proteins, with TM-scores of 0.99 and 0.96 for
HMG-box A and B, respectively (Figure 1b).
Figure 1. (a) In silico comparison of Ixr1 amino acid sequence from S. cerevisiae and K. lactis.(upper)
Scheme of protein domain distribution in Ixr1 protein from S. cerevisiae and K. lactis. (lower) Pairwise
alignment of the Ixr1 double HMG-box domains arranged in tandem from S. cerevisiae (Uniprot
code P33417) and K. lactis (Uniprot code Q6CMQ4). Conserved amino acids are highlighted in bold
and conserved regions indicated by grey boxes. Small and hydrophobic amino acids (less tyrosine)
are indicated in red, acidic amino acids in blue, basic amino acids (less histidine) in magenta and
hydroxyl + sulfhydryl + amine (STYHCNGQ) in green. (b) Model superposition of HMG-box A
(S. cerevisiae in dark green and K. lactis in dark blue) and HMG-box B (S. cerevisiae in light green and
K. lactis in light blue). Enlarged frames show the conserved aromatic residues that form the cluster
stabilizing the three-helix HMG folding.
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The function of the HMG-box domains in DNA binding have been proven in ScIxr1 [6]
and their interaction with DNA has been postulated as a mechanism that, interfering with
the machineries of DNA repair, increases cisplatin cytotoxicity [6,27,28]. More recently, we
demonstrated that ScIxr1 participates in the yeast response to cisplatin treatment through
the control of ribosome biogenesis by direct binding to promoters of specific genes that
regulate rRNA, ribosomal proteins, and RiBi (Ribosone Biogenesis) gene expression, as
well as partial overlapping of ScIxr1 targets and TOR (Target of Rapamycin) signaling
pathway components that regulate cell proliferation [29,30]. Since the HMG domains
are the only well conserved regions between ScIxr1 and KlIxr1, we tested if heterologous
expression of KLLA0E18481g (KlIXR1) in S. cerevisiae could complement the increased resis-
tance to cisplatin observed in the S. cerevisiae ixr1∆ deletion mutant. The S. cerevisiae strains
W303 and its isogenic derivative W303-ixr1∆ [37] were transformed with the construction
YEplac195-KlIXR1 and cisplatin sensitivity was analyzed in plate by serial dilutions pre-
pared from cultures at logarithmic growth or stationary phase, as described in Materials
and Methods. From results obtained (Figure 2), the absence of complementation for this
phenotype between KlIxr1 and ScIxr1 is concluded in both growth phases.
Figure 2. Effect of cisplatin treatment on cell growth (in logarithmic and stationary phase) of strain
W303 and derivatives. ixr1∆ null strain was transformed with the plasmid pAG426GAL-ccdB, either
empty (Ø), or containing the IXR1 ORFs from S. cerevisiae or K. lactis under the control of the GAL1
promoter. Serial dilutions of the cells (1, 10−1, 10−2, 10−3, 10−4, 10−5; from left to right) were made
from an initial culture of OD600 = 1.0 and were grown at 30 ◦C for three days on YPGal plates with
different concentrations of cisplatin as specified.
3.2. KlIXR1 Is Not Related to Cisplatin Sensitivity in K. lactis
Since KlIXR1 was unable to complement the function of the ScIXR1 gene increasing
cisplatin citotoxicity, we constructed a K. lactis ixr1∆ null strain to test whether the pheno-
type was intrinsically observable in K. lactis. The results show that deletion of KlIXR1 does
not increase cisplatin resistance as reported for the ScIXR1 gene deletion in S. cerevisiae [27],
but oppositely, the cytotoxic effect of the drug was increased in the MW190-9b-ixr1∆ null
mutant (Figure 3a). Cisplatin has a cytotoxic effect upon K. lactis cells similar to that caused
upon S. cerevisiae; however, genes related to this phenotype have not been directly studied
in K. lactis yet.
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Figure 3. Study of the cellular response of MW190-9b strain (black) and its derivative ixr1∆ (red) to
cisplatin treatment. (a) Resistance to cisplatin in the wild type and klixr1∆ null strains. Cells from
the K. lactis strain MW190-9B and its isogenic derivative MW190-9B-ixr1∆ were treated with several
concentrations of cisplatin (0, 50, 100, 200, 400, and 600 µM). After 24 h of growth at 30 ◦C, optical
density measurements at 600 nm were taken, and survival rates were calculated by normalization
from untreated cultures. (b) rRNA cellular content determination by microfluidic-based automated
electrophoresis. (c) mRNA levels of KlSFP1, KlCRF1, KlSCH9, KlTOR1, KlRAP1, KlIFH1, KlFHL1, and
KlDOT6 were analyzed by RT-qPCR, before (solid) and after (streaked) the treatment with 600 µM of
the chemotherapeutic agent cisplatin. Housekeeping gene KlTAF10 was used for gene normalization.
* p < 0.05; ** p < 0.01.
3.3. KlIxr1 Controls the Expression of Genes Related to rRNA Processing and Ribosome Biogenesis
in K. lactis
Considering that we had previously found in S. cerevisiae that ScIxr1 regulates the
rRNA processing machinery [24], rRNA cellular content was measured by microfluidics-
based automated electrophoresis instruments in the K. lactis ixr1∆ null strain and control.
Figure 3b shows that KlIxr1 cellular depletion decreases 25S and 18S rRNA levels, similarly
to that previously observed for S. cerevisiae [24]. In S. cerevisiae, this regulation was mediated
by transcriptional ScSFP1 (Split Finger Protein 1) upregulation and ScCRF1 (Co-Repressor
with FHL1) downregulation [29]. ScSfp1 is a transcription factor mainly involved in regula-
tion of RiBi genes, but also of ribosomal proteins, by protein translocation from cytoplasm
to nucleus after rapid TORC1 kinase activation under growth promoting conditions [47].
Conversely, ScCrf1 is a transcriptional repressor, activated by ScYak1 (Yet Another Kinase 1)
phosphorylation via TOR and PKA pathways during carbon and nitrogen starvation or
oxidative stress conditions, to displace the paralogue ScFhl1 (Fork Head-Like 1) and re-
press ribosomal protein genes [48]. To analyze regulatory parallelisms in TOR signaling
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pathways in S. cerevisiae and K. lactis, mRNA levels of KlSFP1 (KLLA0B03047g) and KlCRF1
(KLLA0F13222g) genes were measured by RT-qPCR in the absence and presence of cisplatin.
The results show that KlIxr1 depletion downregulates the KlSFP1 gene, meanwhile the
repressor KlCRF1 gene is upregulated (Figure 3c), indicating that KlIxr1 regulation exerted
on ribosome synthesis processes through these two regulators in K. lactis is identical to that
observed previously in S. cerevisiae [29].
Additionally, intracellular mRNA levels of another eight genes related to TOR signal-
ing pathway were analyzed by RT-qPCR, including KlABF1 (KLLA0F02970g, previously re-
lated to ScIXR1 regulation [29]), as well as KlSCH9 (KLLA0B03586g), KlTOR1 (KLLA0B13948g),
KlRAP1 (KLLA0D19294g), KlIFH1 (KLLA0F13222g), KlFHL1 (KLLA0F08206g), and KlDOT6
(KDROE02480). With the exception of ScSch9 and ScTor1 kinases, the other four genes code
for transcription factors involved in the regulation of ribosomal protein genes in response
to nutritional availability. When nutrients are available, ScRap1 (Repressor/Activator
site binding Protein 1), ScIfh1 (Interacts with Fork Head 1), and ScFhl1 bind to ribosomal
protein genes and promote active transcriptional rates. Under nutritional stress, ScAbf1
(ARS-Binding Factor 1) is incorporated and ScIfh1 dissociates to minimize ribosomal
protein gene expression and to inhibit cell growth [49]. ScSch9, another TORC1 direct phos-
phorylation target that acts through ScSfp1, is a positive regulator of ribosomal protein and
RiBi gene expression [50]. Figure 3c shows that the absence of KlIxr1 protein reduces the
transcriptional levels of KlTOR1, but surprisingly KlIFH1 is highly upregulated, suggesting
that different mechanisms have a direct or indirect influence in K. lactis regulation of the
expression of these genes.
It was previously found that there is a functional link between the response to cisplatin
treatment and regulation of the rRNA processing machinery by ScIxr1 in S. cerevisiae [29].
We also analyzed this possibility in K. lactis, but obtained results did not show any signifi-
cant effect of cisplatin treatment in this regulatory mechanism (Figure 3c).
3.4. KlIXR1 Regulates the Expression of the KlHEM13 Gene
We have previously described that ScIxr1 from S. cerevisiae controls the aerobic repres-
sion and hypoxic activation of genes involved in the adaptation to oxygen levels, including
ScHEM13 [24]. With the aim to elucidate whether a similar regulatory role is functional for
KlIxr1 in K. lactis, we analyzed the transcriptional levels of KlHEM13 (KLLA0F20075g) from
the K. lactis strain MW190-9B and its isogenic derivative MW190-9B-ixr1∆, in normoxic
and hypoxic conditions, by Northern blot (Figure 4a) and Real-time qPCR experiments
(Figure 4b). The results demonstrated that KlIxr1 acts as a transcriptional activator in
both conditions, independently of oxygen levels. Additionally, we tested the possibility
that KlIxr1 would exert a cis regulation on KlHEM13 promoter. In silico analysis of the
KlHEM13 promoter region, using the AYKGTT core sequence for ScIxr1 sequence-specific
DNA binding, rendering two possible binding sites, both situated very closely between
–373 and –352 positions from the translational start site of KlHEM13. EMSA assays showed
that the KlIxr1 protein is able to interact to both binding sites, observing two retarded
bands, which correlate with stoichiometry 1:1 and 2:1 (protein: ligand) (Figure 5a). To
calculate equilibrium dissociation constants, both putative binding sites were analyzed by
fluorescence anisotropy. The results showed that binding affinity of KlIxr1 for the first site
(ATCTTGAATGTATGTTGGTTCAGCCTCTCC) is in the low nanomolar range, meanwhile
the binding affinity for the second site (TGGCCCAGCCTCTATTTCTCTCGTACCGGT)
is ten times lower (Figure 5b,c). Additionally, mutations of the putative core sequences
combined with EMSA or FA assays indicate that KlIxr1 protein binds to both sites in a
sequence-specific manner (Figure 5a,c).
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Figure 4. Effect of KlIXR1 disruption on KlHEM13 expression under aerobic (solid) or hypoxic conditions (grid) in the
MW190-9b strain from K. lactis were analyzed by (a) Northern blot and (b) RT-qPCR experiments. Blots for (a) were obtained
in triplicate experiments and a representative picture is shown in upper left panel. KlSNR17A and KlTAF10 signal levels
were used as references for normalization in (a,b), respectively. * p < 0.05; ** p < 0.01.
3.5. KlIxr1 Is Implicated in the Response to Hydrogen Peroxide and Cadmium-Metals
We had previously demonstrated the implication of ScIxr1 in the cellular response to
hypoxia [24] and oxidative stress, two conditions tightly connected in S. cerevisiae [51]. With
the aim to determine regulatory parallelisms in K. lactis, the wild-type strain MW190-9b and
its derivative ixr1∆ null mutant were grown in the presence of increasing concentrations
of hydrogen peroxide. Figure 6a shows that the strain MW190-9b-ixr1∆ was less resistant
to oxidative stress caused by 0.5 or 2 mM H2O2, indicating that KlIxr1 is also important
for conferring resistance to such stress. Additionally, and since oxidative stress can be also
induced by high concentrations of metals [52], we tested the effect of cadmium. A sensitive
phenotype was found in the ixr1∆ null mutant to the presence of 10 and 50 µM of cadmium
(Figure 6a). Yeast Cadmium Factor 1 (ScYCF1) is one of the main cellular elements to confer
cadmium resistance in S. cerevisiae through a mechanism causing vacuolar sequestration of
GSH-conjugated cadmium, bis (glutathionate) cadmium (Cd-GS2) [53–55]. It was reported
that KlRox1 regulates the expression of KlYCF1 gene and mediates the response to cadmium
metals [35]. The analysis of the KlYCF1 promoter region (KLLA0F20075g) by RSA tools
provided two consecutive putative KlIxr1 binding regions at -568 and -562 positions from
the coding start codon. In order to analyze the relationship between cadmium resistance
associated to KlIXR1 gene expression and a possible cis regulatory role of KlIxr1 protein
on KlYCF1 promoter, EMSA assays were performed. Figure 6b shows that KlIxr1 binds to
KlYCF1 promoter sequences containing both putative sites. These binding evidences lower
affinity (Kd = 105.26 ± 18.85 nM) in comparison with binding to the KlHEM13 promoter
region (with Kd = 15.59 ± 4.27 nM for HEM13A and Kd = 154.88 ± 38.58 nM for HEM13B)
(Figures 5 and 6).
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Figure 5. Analysis of KlIxr1 protein binding to the KlHEM13 promoter region. (a) EMSA assays show-
ing sequence specificity to both binding sites found using the consensus sequences YYYATTGTTCTC
and KTTSAAYKGTTYASA previously described [23,24]. Competition assays were conducted with
increasing amounts of non-labeled ligands indicated. WT: ligand not mutated; M1: ligand mutated in
first site; M2: ligand mutated in second site; NB: no retarded band (no protein added). (b) Klotz plots
representing quantitative analysis of KlIxr1 binding to both KlHEM13 promoter deduced sites. DNA
binding measured by fluorescence anisotropy changes of the 5′ fluorescein-labelled DNA (100 nM
ligand) upon protein titration (see Section 2). The resulting semi-log binding isotherms were fitted
to a 1:1 binding model with non-linear least squares regression. Data points are the average of
3 independent experiments, error bars representing standard deviations. HEM13A: first binding
site deduced from KTTSAAYKGTTYASA [23] consensus sequence; HEM13B: second binding site
deduced from YYYATTGTTCTC [24] consensus sequence; * indicates FAM labeled ligand. (c) Klotz
plots representing competition analysis of KlIxr1 binding to both KlHEM13 promoter-assayed sites.
DNA binding measured by fluorescence anisotropy changes of the 5′ fluorescein-labelled DNA
(100 nM ligand) bound to KlIxr1 protein (200 nM) and upon non-labeled DNA competitor titration
(see Section 2). The resulting semi-log binding isotherms were fitted to a logIC50 competitive model
with non-linear least squares regression. * indicates FAM labeled ligand.
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Figure 6. Analysis of the cellular response of MW190-9b strain and its derivative ixr1∆ to hydrogen
peroxide and cadmium treatments. (a) Resistance to H2O2 and cadmium in the wild type and klixr1∆
null strains. Serial dilutions of the cells (1, 10−1, 10−2, 10−3, 10−4, 10−5; from left to right) were
made from an initial culture of OD600 = 1.0 and were grown at 30 ◦C for three days on CM plates
supplemented with the indicated concentrations of compound. (b) EMSA assays for the KlYCF1
promoter region contains two putative contiguous binding sites for KlIXR1 deduced by using the
AYKGTT core consensus sequence [23] in silico searches. Competition assays were conducted with
increasing amounts of non-labeled ligands indicated. WT: ligand not mutated; M1: ligand mutated
in first site; M2: ligand mutated in second site. (c) Klotz plots representing quantitative analysis of
KlIxr1 binding to KlYCF1 promoter-deduced site. DNA binding measured by fluorescence anisotropy
changes of the 5′ fluorescein labelled DNA (100 nM ligand) upon protein titration (Section 2). The
resulting semi-log binding isotherms were fitted to a 1:1 binding model with non-linear least squares
regression. Data points are the average of 3 independent experiments. Competition analysis of KlIxr1
binding to both KlYCF1 promoter deduced sites were measured by fluorescence anisotropy changes
of the 5′ fluorescein labelled DNA (100 nM ligand non mutated) bound to KlIxr1 protein (200 nM)
and upon non-labeled DNA competitor titration (KlIxr1 binding sites individually mutated). The
resulting semi-log binding isotherms were fitted to a logIC50 competitive model with non-linear
least squares regression. * indicates FAM labeled ligand.
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3.6. Deletion of KlIXR1 Causes Petite Colonies That Are Not Related to Carbon Source, Cell Cycle
Control, or Defects in Heme Production
A phenotype observed in the K. lactis ixr1∆ null strain and not previously reported
for the S. cerevisiae ixr1∆ null strains is the smaller size of the colonies (petites). We further
investigated this phenotype by diverse approaches. We first verified if the phenotype
was dependent on carbon source and we found that it is produced both in fermentable
(glucose) and non-fermentable (glycerol) carbon sources (Figure 7a). The observation
of petite growth in K. lactis also in glucose could be attributable to a minor fermentative
capacity in K. lactis than in S. cerevisiae. Therefore, the growth defect caused by KlIxr1
depletion is not compensated by fermentative metabolism. Additionally, and considering
that KlIxr1 activates the transcription of the KlHEM13 gene as above reported, we also
tested if this phenotype could be attributed to heme deficiency/shortness. To test this
hypothesis, we plate the strain in media supplemented with hemin and results show that
externally provided heme-precursor does not overcome this growth decrease (Figure 7a).
Figure 7. Analysis of petite phenotype in MW190-9b ixr1∆ null mutant. (a) (left) Colony size of
MW190-9b strain and its derivative ixr1∆ in 2% w/v glucose, 2% w/v glycerol, or 2% w/v glucose
supplemented with 50 µg/mL hemin. (right) Growth tracking of MW190-9b strain (black) and its
derivative ixr1∆ (red) 2% w/v galactose or 2% w/v glycerol during 48h. Growth rates were calculated
using respective 2% w/v glucose cultures as normalization elements. (b) RT-qPCR results of KlABF1,
KlTEC1, KlSOK2, KlUME6, and KlDAL81 genes in wild-type (black) and ixr1∆ null strain (red),
before (solid) and after (streaked) the treatment with 600 µM of the chemotherapeutic agent cisplatin.
Housekeeping gene KlTAF10 was used for gene normalization. * p < 0.05; ** p <0.01. (c) Cellular
response to cycloheximide treatment. Cell cultures of the K. lactis strain MW190-9B (black) and its
isogenic derivative MW190-9B-ixr1∆ (red) were treated with several concentrations of cycloheximide
(0, 25, 50, 100, 200, and 300 µg/mL). After 24 h of growth at 30 ◦C, optical density measurements at
600 nm were taken, and survival rates were calculated by normalization from untreated cultures.
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Transcriptomic data revealed ScIxr1 is a master regulator of regulators related to cell
cycle progression and cell growth [29], since ScIxr1 function modulates mRNA levels of
several key transcriptional factors associated to these processes, including ScTEC1 (Trans-
poson Enhancement Control 1), ScSOK2 (Suppressor Of Kinase 2), ScUME6 (Unscheduled
Meiotic gene Expression 6) (KDROA03340), or ScDAL81 (Degradation of Allantoin 81)
(KDROE03280) among others [29]. ScTec1 participates in the regulation of several signaling
pathways, which respond to nutrient availability in a TOR1C-dependent manner, and
control cellular developmental programs [56]. On the other hand, ScSok2 interacts with the
ScTup1-ScCyc8 co-repressor complex to downregulate the expression of certain genes under
plenty nutrient availability [57–59]. In K. lactis, deletion of KlIXR1 decreases significantly
the mRNA levels of KlSOK2 (KLLA0F04840g), meanwhile KlTEC1 (KLLA0E12497g) was
upregulated (Figure 7b). More surprisingly, KlIxr1 depletion causes a resistant phenotype
in presence of the protein translation inhibitor cycloheximide (Figure 7c), which blocks
meiosis by cell cycle arrest at G1 phase.
3.7. KlIxr1 and the Regulation of Genes Related to De Novo dNTP Synthesis
In S. cerevisiae, during the normal cell cycle, the adequate supply of dNTPs, which
are necessary for DNA synthesis, is regulated through modulation of the activity of ri-
bonucleotide reductase (RNR) or the expression of the RNR genes [60]. The genes ScRNR1
and ScRNR3 encode the large subunit of RNR and ScRNR2 and ScRNR4 encode the small
subunit. Transcriptional regulation of ScRNR3, ScRNR2, and ScRNR4 is repressed by the
transcriptional factor ScCrt1 (Regulatory Factor X 1) and its phosphorylation, which is
ScMec1-ScRad53-ScDun1–dependent after DNA damage or replication stress, promotes
activation of their transcription [61]. The kinase activity of ScDun1 (DNA-damage Unin-
ducible 1) also targets for degradation ScSml1 (Suppressor of Mec1 Lethality 1), a protein
inhibitor of RNR, and ScDif1 (Damage-regulated Import Facilitator 1), a protein that regu-
lates the nuclear retention of ScRnr2 and ScRnr4, thus promoting RNR activity [62]. ScRox1
and ScMot3 participates in ScRNR3, ScRNR2, and ScRNR4 repression [63]. The transcrip-
tion of ScRNR1 is independent of ScCrt1, ScRox1, and ScMot3. The deletion of ScIXR1
results in decreased dNTP levels due to a reduced ScRNR1 expression and to ScIxr1 binding
to the ScRNR1 promoter. The control of ScRNR1 by ScIxr1 is ScMec1-ScRad53 dependent,
but independent of ScDun1 [31].
The biosynthesis of dNTPs has not been studied in K. lactis, but exploring the sequence
of the K. lactis genome we have found similarities and differences in the putative homologs
of the genes related to the control of the dNTPs pool in comparison with S. cerevisiae. In
K. lactis there are two ORFs (KLLA0C07887g and KLLA0F01188g) encoding proteins with
significant homology to S. cerevisiae ScRnr1 and ScRnr3, the large subunits of RNR. It is not
possible to establish a unique correspondence based merely in their sequence similarity,
since KLLA0C07887g is more similar to both ScRnr1 and ScRnr3 than KLLA0F01188g.
Regarding the small subunit of RNR in K. lactis, there is only one gene encoding this
subunit (KLLA0F15103g). The machinery of signal transduction after DNA-damage or
replicative stress (ScRad53, ScMec1 and ScDun1) is well conserved between both yeast
species. However, there is low conservation of the transcriptional regulators ScCrt1,
ScCrt10 [64] (absent) or other regulatory factors affecting RNR activity like ScSml1 or ScDif1.
RT-qPCR experiments were carried out in order to assess the role of KlIxr1 in the
regulation and maintenance of dNTPs pools by analyzing the transcriptional levels of the
regulators KlMEC1 (KLLA0C15785g) and KlDUN1 (KLLA0E01585g) and the ribonucleotide
reductase genes KlRNR1 and KlRNR2. The results showed that there exists a clear paral-
lelism between transcriptional regulation of this pathway in S. cerevisiae and K. lactis. In
this sense, KlRNR1 is downregulated in the K.lactis ixr1∆ strain. However, KlRNR2 and the
key regulators KlMEC1 and KlDUN1 (upstream of ScIXR1 in the regulatory pathway of
S. cerevisiae) are not affected by KlIXR1 deletion (Figure 8).
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Figure 8. Regulatory role of KlIxr1 in the KlMec1-KlRad53-KlDun1–dependent ribonucleotide reduc-
tase pathway of K. lactis. mRNA levels of KlMEC1, KlDUN1, KlRNR1, and KlRNR2 were analyzed
by RT-qPCR in the MW190-9b strain (black) and its derivative ixr1∆ (red), before (solid) and after
(streaked) the treatment with 600 µM of the chemotherapeutic agent cisplatin. Housekeeping gene
KlTAF10 was used for gene normalization. * p < 0.05; ** p < 0.01.
Additionally, we have analyzed transcript levels of these genes in the presence of
600 µM cisplatin to induce DNA lesions. The results obtained showed that the expression
KlRNR1 and KIRNR2 is increased in the wild-type, meanwhile the reduction of KlRNR1
transcript levels in the Klixr1∆ null strain are even more abrupt (Figure 8), as previously de-
scribed for S. cerevisiae in the presence of 4-nitroquinoline 1-oxide (4-NQO) or hydroxyurea
(HU) [31].
4. Discussion
Nowadays, eukaryotic unicellular models are useful for the easy study of orphan
genes without assigned functions and for massive screening of drug targets. Most studies
about the hypoxic and oxidative stress responses in eukaryotes, and their connections, were
developed initially on S. cerevisiae cells with a predominant fermentative metabolism [34].
S. cerevisiae mutants have been widely used as research models in aging [65] or in human
pathologies [66]. Frequently, the mechanisms discovered with this yeast proved to be
conserved in multicellular eukaryotes. However, human cells, including those from the
nervous system, have usually a respiratory metabolism, differing from S. cerevisiae cells. In
this sense, K. lactis arises as an alternative eukaryote model more suitable for studies about
the nervous system or their pathologies, since this yeast has a predominantly respiratory
metabolism, although sharing essential regulatory machineries with S. cerevisiae [67]. Also
important for the selection of K. lactis as an eukaryotic model is the fact that it is evolutionary
derived from an ancestral yeast previous to the whole-genome duplication (WGD) that took
place over 100 million years ago and resulted later, after genomic losses and chromosome
reorganizations, in the existence of two copies of some genes in S. cerevisiae [68]. Each
paralog likely sub-functionalized to carry out some, but not all, of its previous functions so
that, a more complex functional network arose [69].
HMGB proteins are not extensively studied in K. lactis, although their transcriptional
regulatory function might predictably influence the respiratory metabolism of this yeast.
In the present work, we show evidence of the cellular functions of the HMGB protein
KlIxr1, finding parallelisms with ScIxr1 functions controlling the expression of genes that
are modulators of oxidative metabolism and oxidative stress response, dNTP cellular levels,
and ribosome biogenesis.
In S. cerevisiae, one of the principal sensors in the yeast response to changes in oxygen
levels is heme, since its enzymatic synthesis is oxygen-dependent. The heme biosyn-
thetic pathway is well conserved between S. cerevisiae and K. lactis. Both yeasts have
eight genes encoding the enzymes for the biosynthesis of heme, and up to three (Kl-
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HEM1, KlHEM12, and KlHEM13) share functional equivalence confirmed experimentally
by cross-complementation [70–72]. Although K. lactis homologs of key regulators (ScHap1
and ScRox1) of the biosynthesis of heme in S. cerevisiae have been characterized, their se-
quence and function diverge notably from those described in S. cerevisiae [35,73]. Here, we
show that transcriptional activation of KlHEM13 is also dependent on the HMGB protein
KlIxr1p, as occurred with ScIxr1 in S. cerevisiae [24]. Moreover, both proteins share similar
DNA binding sequences in their target promoters, as shown by EMSA and fluorescence
anisotropy experiments.
Several S. cerevisiae genes that are induced during hypoxia are also related to the
oxidative stress response caused by hydrogen peroxide or metals, including ScCUP1
(CUPrum 1), ScCUP2 (CUPrum 1), ScHSP12 (Heat Shock Protein 12), ScFMP46 (Found
in Mitochondrial Proteome 46), ScGRE1 (stress Responsive Gene 1), ScALK1, ScMGM1
(Mitochondrial Genome Maintenance 1), or ScSOD1 (SuperOxide Dismutase 1), among
others [51,65,74]. In this sense, we confirmed that depletion of KlIxr1 protein in K. lactis
also produces an increased sensitivity to the presence of hydrogen peroxide and cadmium
metal, as occurred in S. cerevisiae [23,75]. Furthermore, we show for the first time that
KlIxr1 is implied in the transcriptional regulation of the KlYCF1 gene, involved in cadmium
detoxification, and binds to its promoter. Interestingly, other regulators of the respiratory
metabolism in response to changes of oxygen levels, KlHap1 and KlRox1, have been
previously related to the oxidative stress response in K. lactis [30,37].
It was previously described that the role of ScIxr1 is as a “regulator of regulators”
directly or indirectly controlling the expression of a set of 33 yeast transcriptional factors
mostly involved in the regulation of cell growth and cell cycle progression. These transcrip-
tional regulators are downregulated in the Scixr1∆ mutant strain [29]. In S. cerevisiae, these
regulatory networks sense nutrient availability, external stimuli, or DNA damage through
TOR complexes known as Tor Complex 1 (ScTORC1, TOR complex 1) and Tor Complex
2 (ScTORC2, TOR complex 2) [76]. ScTORC1 is sensitive to rapamycin and controls pro-
tein synthesis, mRNA synthesis and degradation, ribosome biogenesis, and autophagy.
Rapamycin is currently used clinically as an immunosuppressive drug for organ and tissue
transplant recipients and a chemotherapy agent against a variety of solid cancers because
of its antiproliferative properties [77]. S. cerevisiae cells treated with rapamycin display phe-
notypes associated with nutrient depletion including G1 cell cycle arrest, cellular volume
expansion, protein synthesis inhibition, glycogen accumulation, and autophagy [78]. In
K. lactis, although only a TOR complex exists, we have found that KlIxr1 is also implied in
the control of ribosomal production and cellular growth by regulation of rRNA levels, as
well as transcription of several RiBi genes and other transcriptional factors that modulate
ribosomal protein gene expression, including KlSFP1, KlCRF1, KlTOR1, or KlIFH1.
Cellular division depends on the maintenance of dNTP pools for DNA synthesis and
genes encoding ribonucleotide reductases (RNR) are tightly regulated [26]. We have also
shown that KlIxr1 modulates transcriptional activation of the KlRNR1 gene, a mechanism
previously described in S. cerevisiae [31]. RNR expression is tightly controlled by the genome
integrity checkpoint, a conserved signaling pathway that is regulated in S. cerevisiae by the
ScMec1 (homologous to human ATR) and ScRad53 (homologous to human Chk1) kinases.
Under DNA damage or DNA replication stress, this pathway promotes the activation of
ScRNR2, ScRNR3, and ScRNR4 through the ScMec1-ScRad53-ScDun1 kinase cascade, which
targets and inactivates the transcriptional inhibitor ScCrt1 [62]. However, upregulation
of ScRNR1 in response to DNA damage requires ScMec1 and ScRad53, but not ScDun1.
If this molecular mechanism is also maintained, K. lactis will need to be elucidated in
future experiments.
It is interesting to note that despite all similitudes found between KlIxr1 and ScIxr1,
showing that KlIxr1 is also a master regulator of oxidative metabolism, oxidative stress
response, cell growth, and cell division in K. latis, several functions are not conserved
between ScIxr1 and KlIXr1. We have found that KlIxr1p is not able to supplement the
absence of ScIxr1 in S. cerevisiae and unable to revert the phenotype of increased resistance
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to cisplatin treatment associated to the null mutation [37]. Furthermore, KlIXR1 gene
knockout generates the opposite phenotype in K. lactis, conferring a sharp sensitivity to
cisplatin treatment. Some transcriptional regulators that were previously related to cisplatin
resistance or ribosomal biosynthesis in S. cerevisiae [73–75] are also differently regulated
by ScIxr1 and KlIxr1 in both species, respectively. We have observed these differences
comparing mRNA changes of KlABF1, KlUME6, or KlDAL81 after KlIxr1 depletion with
those previously reported in S. cerevisiae after ScIXr1 depletion [29]. Related to this, we have
found that KlIxr1 depletion causes a resistant phenotype to cyclohexymide not previously
described for the Scixr1∆ null mutant, and that could be associated to alterations of certain
ribosomal protein targets of the drug [76], among other causes. Future structural studies are
necessary to dilucidate if non-conserved domains in the Ixr1 proteins from S. cerevisiae and
K. lactis are responsible of differences observed in their functions in reference to responses
to cisplatin or cyclohexymide treatments.
5. Conclusions
Taken together with the data reported here, Ixr1 from K. lactis shows similarities with
its S. cerevisiae counterpart to how these two proteins participate in the transcriptional
regulation of genes related to cellular growth, dNTP levels, and ribosome biosynthesis, as
well as of genes implicated in the cellular response changes in oxygen availability, which
consequently alters cellular levels of heme and ROS. This supports the idea that these
regulation mechanisms are essentially well conserved for Ixr1 in S. cerevisiae and K. lactis
yeasts, which differ in lifestyle with respect to carbon sources. However, the finding of
new roles for KlIxr1 protein in the response to platinum compounds and the occurrence
of a petite phenotype after KlIXR1 gene deletion reveal that it is necessary to further
understanding of the mechanisms of KlIxr1 function and also a broader knowledge of the
regulatory pathways associated to all these processes in K. lactis.
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KlIxr1 purification.
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